Saraf, TT&A facilitate Fortis’ $207 mln buyout of PE investors in Agilus Diagnostics
BY Nimitt Dixit |
Saraf and Partners has acted for Fortis Healthcare in relation to the $207 million acquisition of a 31.5 percent equity stake in its subsidiary, Agilus Diagnostics, from three private equity investors.